Multidimensional disease burden of atopic dermatitis in children from a real-world case study – Presentation from the ADVENT symposium at EAACI 2023.
In this ADVENT symposium at the 2023 EAACI congress, "Targeting Type 2 Inflammation in Children with Atopic Dermatitis: Opportunity for Early Intervention?”, Stephan Weidinger, MD, PhD (University Hospital Schleswig-Holstein), Peter Arkwright, MD, PhD (University of Manchester), and Oscar Palomares, PhD (University of Madrid) discussed the multidimensional disease burden of atopic dermatitis in children, the pathophysiology of the disease driven by type 2 inflammation, and the current treatment landscape for pediatric patients with atopic dermatitis.
Senior Lecturer/Consultant in Paediatric Allergy and Immunology at the University of Manchester and Royal Manchester Children’s Hospital, UK
See author’s profile